Pediatrix Medical Group, Inc. (NYSE:MD) Stock Has Consensus Target Price of $26.60 According to Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned an average rating of “Hold” from the six analysts that are covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $26.60.

MD has been the subject of a number of recent analyst reports. UBS Group boosted their price objective on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Weiss Ratings raised shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, September 9th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and boosted their price target for the stock from $27.00 to $28.00 in a report on Wednesday, August 19th. Wall Street Zen upgraded shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 13th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $25.00 target price on shares of Pediatrix Medical Group in a research report on Wednesday, August 5th.

Pediatrix Medical Group Price Performance

NYSE:MD opened at $27.23 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.45. Pediatrix Medical Group has a 52 week low of $16.47 and a 52 week high of $28.02. The stock’s 50-day moving average price is $26.48 and its 200-day moving average price is $24.76. The stock has a market capitalization of $2.21 billion, a PE ratio of 13.03 and a beta of 0.61.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.59 by $0.04. The company had revenue of $487.78 million during the quarter, compared to analysts’ expectations of $478.49 million. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%. Pediatrix Medical Group’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.53 EPS. As a group, equities analysts expect that Pediatrix Medical Group will post 2.17 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of MD. BlackRock Inc. purchased a new stake in shares of Pediatrix Medical Group during the second quarter worth $347,383,000. Wasatch Advisors LP acquired a new stake in shares of Pediatrix Medical Group in the first quarter valued at about $43,861,000. Bank of New York Mellon Corp purchased a new position in shares of Pediatrix Medical Group in the second quarter worth about $14,297,000. Rockefeller Capital Management L.P. lifted its stake in shares of Pediatrix Medical Group by 814.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company’s stock worth $12,713,000 after buying an additional 529,367 shares in the last quarter. Finally, Empowered Funds LLC purchased a new position in shares of Pediatrix Medical Group in the second quarter worth about $12,668,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc provides physician-led health care services to hospitals, health systems and patients across the United States. The company focuses on specialized care for women, infants and children, supporting patients in hospital-based and affiliated clinical settings.

Its services include neonatal and perinatal care, maternal-fetal medicine, pediatric cardiology and other pediatric subspecialties. Pediatrix physicians commonly practice in neonatal intensive care units, delivery rooms, pediatric emergency departments and other hospital departments, working with care teams to manage complex medical needs.

The company was founded in 1979 and operated for many years under the name MEDNAX, Inc It adopted the Pediatrix Medical Group name in 2023 as part of a broader effort to emphasize its pediatric, neonatal and maternal-fetal health care businesses.